- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02944149
Safety of Minilaparotomy Provided by Trained Clinical Officers and Assistant Medical Officers: a Non-inferiority Trial
August 1, 2017 updated by: EngenderHealth
The study is a non-inferiority randomized controlled trial (RCT) that aims to demonstrate that tubal ligations by minilaparotomy (ML) conducted by trained clinical officers (COs) are no less safe as compared to those conducted by assistant medical officers (AMOs) in Tanzania.
Participants will be randomized in a one to one ratio to ML by a CO and ML by an AMO.
In addition to the screening and enrollment/ML visit, there will be three scheduled follow-up visits at 3, 7 and 42 days post-surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The primary objective is to establish whether the safety of ML provided by trained COs is not inferior to the safety of ML provided by trained AMOs, as measured by rates of major adverse events (AEs) among women undergoing ML.
The primary outcome is safety, defined by the overall rate of major AEs following ML.
The investigators will address the primary objective by comparing the rate of major AEs observed following MLs conducted by COs vs. AMOs during the ML procedure and through 42 days follow-up.
This study will be conducted among 1,970 women 18 years of age and older presenting at study sites for ML surgery.
The duration of a woman's participation in the study is expected to be 6 weeks, unless additional follow-up beyond 42 days is clinically indicated due to complications or for other reasons.
The study will be conducted in Arusha Region in northern Tanzania.
The following health facilities will serve as study sites: Daraja Health Centre, Karatu Hospital, Kaloleni Health Centre, Levolosi Urban Health Centre, Longido Health Centre, Monduli Hospital, and Mto wa Mbu Health Centre.
Study Type
Interventional
Enrollment (Actual)
1970
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arusha Region
-
Arusha, Arusha Region, Tanzania
- Daraja Health Centre
-
Arusha, Arusha Region, Tanzania
- Kaloleni Health Centre
-
Arusha, Arusha Region, Tanzania
- Levolosi Health Centre
-
Karatu, Arusha Region, Tanzania
- Karatu Lutheran Hospital
-
Longido, Arusha Region, Tanzania
- Longido Health Centre
-
Monduli, Arusha Region, Tanzania
- Monduli District Hospital
-
Monduli, Arusha Region, Tanzania
- Mto Wa Mbu Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Aged 18 years and older;
- Requested and consented to female sterilization AND additionally freely consents to participate in the study and signs a study informed consent form;
- Is sound of mind, in good general health and deemed suitable to undergo female sterilization by ML in accordance with the Tanzania government guidelines;
- Able to understand study procedures and requirements of study participation;
- Agrees to return to the study site for the full schedule of follow-up visits after her ML procedure;
- Agrees to provide the study staff with an address, phone number, close relative, and/or other locator information while participating in the research study.
Exclusion Criteria:
- Pregnancy
- Between 8 and 42 days postpartum or postabortion
- Known allergy or sensitivity to lidocaine or other local anesthesia
- Takes a medication that would be a contraindication for elective surgery, such as an anticoagulant or steroid
- Previous abdominal or pelvic surgery
- Local skin infection near area where incision will be made
- Coagulation disorder
- Hypertension (properly taken measurements; systolic ≥ 160 or diastolic ≥ 100 mm Hg)
- Acute deep venous thrombosis/pulmonary embolism
- Current ischemic heart disease
- Unexplained vaginal bleeding
- Malignant gestational trophoblastic disease
- Cervical, endometrial and/or ovarian cancer
- Pelvic inflammatory disease (current or within the last three months)
- Current purulent cervicitis, chlamydial infection and/or gonorrhea
- Current symptomatic gall bladder disease
- Active viral hepatitis
- Severe anemia (irrespective of type or etiology)
- Tuberculosis of pelvic organs
- Acute bronchitis or pneumonia
- Systematic infection or gastroenteritis
- Currently participating in another biomedical research study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: assistant medical officer (AMO)
Assistant medical officers (AMO) are currently allowed to provide tubal ligation by minilaparotomy, however government regulations do not allow clinical officers (COs) to provide this service.
|
Tubal ligation will be performed by minilaparotomy as per the Tanzanian government standards, with the standard family planning counseling and minilaparotomy surgical protocols used by the government being followed during the study.
Other Names:
|
|
Experimental: clinical officer (CO)
Experimental: clinical officer (CO) In Tanzania, COs are mid-level providers who offer diagnosis, treatment, and minor surgeries.
They are more common in rural areas than medical officers (MOs) and assistant medical officers (AMOs) and are generally considered capable of performing minor surgery.
Almost all facilities in Tanzania are understaffed, but COs vastly outnumber MOs and AMOs.
COs are more prevalent in poorer and/or rural areas than other higher level cadres; thus, task-shifting to COs would increase access to tubal ligation by minilaparotomy for many women who are most in need.
|
Tubal ligation will be performed by minilaparotomy as per the Tanzanian government standards, with the standard family planning counseling and minilaparotomy surgical protocols used by the government being followed during the study.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Safety: safety is defined by the overall rate of major adverse events (AEs) during and after the procedure. Rates of major AEs observed during and after procedures conducted by COs vs. AMOs will be compared.
Time Frame: During the minilaparotomy procedure and through 42 days follow-up
|
During the minilaparotomy procedure and through 42 days follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Performance
Time Frame: During the minilaparotomy procedure
|
Performance assessed by (e.g., procedure times, difficulties performing the procedure, inability to complete the procedure, need for assistance to complete the procedure, maximum reported pain experienced by the participant during the procedure) between procedures performed by COs and AMOs will be compared
|
During the minilaparotomy procedure
|
|
Participant satisfaction
Time Frame: During the minilaparotomy procedure and through 42 days follow-up
|
Participant satisfaction with the minilaparotomy experience conducted by COs and AMOs will be compared.
|
During the minilaparotomy procedure and through 42 days follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Mark A Barone, DVM, MS, EngenderHealth
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Barone MA, Mbuguni Z, Achola JO, Almeida A, Cordero C, Kanama J, Marquina A, Muganyizi P, Mwanga J, Ouma D, Shannon C, Tibyehabwa L. Safety of Tubal Occlusion by Minilaparotomy Provided by Trained Clinical Officers Versus Assistant Medical Officers in Tanzania: A Randomized, Controlled, Noninferiority Trial. Glob Health Sci Pract. 2018 Oct 4;6(3):484-499. doi: 10.9745/GHSP-D-18-00108. Print 2018 Oct 3.
- Barone MA, Mbuguni Z, Achola JO, Cordero C, Kanama J, Muganyizi PS, Mwanga J, Shannon C, Tibyehabwa L. Safety of tubal ligation by minilaparotomy provided by clinical officers versus assistant medical officers: study protocol for a noninferiority randomized controlled trial in Tanzanian women. Trials. 2017 Oct 26;18(1):499. doi: 10.1186/s13063-017-2235-6.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2016
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
October 14, 2016
First Submitted That Met QC Criteria
October 23, 2016
First Posted (Estimate)
October 25, 2016
Study Record Updates
Last Update Posted (Actual)
August 3, 2017
Last Update Submitted That Met QC Criteria
August 1, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- TAN-42
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sterilization, Tubal
-
Bartin State HospitalCompletedSterilization, Tubal | SalpingectomyTurkey
-
Mayo ClinicCompletedTubal SterilizationUnited States
-
Jani JacquesRecruiting
-
Centre Hospitalier Universitaire de NīmesTerminated
-
Thomas Jefferson UniversityCompleted
-
Göteborg UniversityUmeå UniversityActive, not recruitingLaparoscopy | Ovarian Reserve | Salpingectomy | Sterilization TubalSweden
-
University of North Carolina, Chapel HillMedtronic - MITGCompletedPrevention & Control | Sterilization, Tubal | Salpingectomy | OvaryUnited States
-
University of PittsburghNational Institute on Minority Health and Health Disparities (NIMHD); University... and other collaboratorsCompletedContraception | Contraception Behavior | Women's Health | Reproductive Behavior | Tubal SterilizationUnited States
-
Alanya Alaaddin Keykubat UniversityCompletedSterilization, Tubal | Visual Analog Pain Scale
-
Shepherd Medical CompanyUnknown
Clinical Trials on tubal ligation by minilaparotomy
-
University of VirginiaCompletedMethod of Tubal Ligation at the Time of Cesarean SectionUnited States
-
Wolfson Medical CenterUnknown
-
Mayo ClinicCompletedContraceptionUnited States
-
BayerCompleted
-
University of Alabama at BirminghamCompletedOvarian CancerUnited States
-
Göteborg UniversityUmeå UniversityActive, not recruitingLaparoscopy | Ovarian Reserve | Salpingectomy | Sterilization TubalSweden
-
University Hospital, ToulouseInstitut National de la Santé Et de la Recherche Médicale, FranceRecruiting
-
Ain Shams UniversityRecruitingPelvic Congestion SyndromeEgypt